Viewing Study NCT03804866


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-03-08 @ 1:58 AM
Study NCT ID: NCT03804866
Status: COMPLETED
Last Update Posted: 2019-01-15
First Post: 2018-10-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)
Sponsor: AGC Biologics S.p.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module